A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial.
Walsh
P
P
Division of Dermatology, University of Colorado Health Sciences Center, Denver 80262, USA.
Gonzalez
R
R
Dow
S
S
Elmslie
R
R
Potter
T
T
Glode
L M
LM
Baron
A E
AE
Balmer
C
C
Easterday
K
K
Allen
J
J
Rosse
P
P
D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D004338:Drug Combinations; D015870:Gene Expression; D015316:Genetic Therapy; D007376:Interleukin-2 / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use*; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis; D010957:Plasmids; D018089:Superantigens / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use; D019444:Vaccines, DNA / Q000627:therapeutic use*
D004338:Drug Combinations; D007376:Interleukin-2; D018089:Superantigens; D019444:Vaccines, DNA